Gestational diabetes mellitus, gestational diabetes Diabetes that develops during pregnancy
Conditions
Interventions
Pharmacologically treatment of GDM.
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: In order to be eligible to participate in this study, a subject must meet all of the following criteria:Either be a:Healthcare professional currently involved in GDM care working in the region of Erasmus MC: gynecologist, internal medicine specialist, midwife (clinical and first-line), diabetes nurse or dietitian, or Patient with GDM who is currently receiving pharmacological treatment or received pharmacological treatment for GDM (= 6 months postpartum).And:Age = 18 years.Proficiency in Dutch or English.Provide informed consent for participation and audio recording of the interview.
Exclusion criteria
Exclusion criteria: No specific exclusion criteria apply.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of barriers and facilitators influencing the implementation of metformin as first-line pharmacological treatment for GDM, based on perspectives of healthcare professionals and patients.Mapping of all determinants to the CFIR domains and constructs: intervention characteristics, outer setting, inner setting, characteristics of individuals, implementation process (see Inteview topic list). | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints focus implementation-relevant perceptions and contextual determinants, aligned with CFIR constructs:Acceptability, perceived advantages/disadvantages, and perceived burden of metformin vs. insulin (intervention characteristics: evidence strength, relative advantage, complexity).Patient needs, resources, and equity considerations (outer setting: patient needs, resources).Implementation climate including compatibility with current practice, incentives, and goals (inner setting: implementation climate).Readiness for implementation, including available resources, leadership engagement, structural support (inner setting: readiness for implementation).Communication, collaboration, and workflow organization, across the care chain and between disciplines (inner setting, implementation process).Task shifting and redistribution of roles between care providers (inner setting, implementation process).Perceived financial/logistic implications, including perceived costs and workload (intervention characteristics, outer setting, inner setting). | — |
Countries
Netherlands
Contacts
Public ContactA.W.T. Wel
Erasmus MC, Universitair Medisch Centrum Rotterdam
Outcome results
None listed